Efficacy and Tolerability of Ombitasvir/Paritaprevir/Ritonavir in HCV Genotype 1-infected Elderly Japanese Patients

Efficacy and Tolerability of Ombitasvir/Paritaprevir/Ritonavir in HCV Genotype 1-infected Elderly Japanese Patients

Introduction and aim. We assessed the characteristics of virological response to a combination treatment of ombitasvir, paritaprevir, and ritonavir in hepatitis C virus genotype 1-infected elderly Japanese patients.Material and Methods. This multicenter prospective study was conducted at six locatio...

Full description

Bibliographic Details
Main Authors: Haruki Uojima, Shuzo Kobayashi, Hisashi Hidaka, Takeshi Kinbara, Tomoaki Fujikawa, Tsuyoshi Nakayama, Hiroki Yamanoue, Takayuki Kanemaru, Tohru Hashimotoh, Ji Hyun Sung, Makoto Kako, Wasaburo Koizumi
Format: Article
Language:English
Published: Elsevier 2019-01-01
Series:Annals of Hepatology
Subjects:
Elderly patients
hepatitis C virus
ombitasvir
paritaprevir
ritonavir
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119303126

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119303126

Similar Items